JC

John Cooke

Stanford University: 38 patents #42 of 5,197Top 1%
VE Vermillion: 6 patents #2 of 49Top 5%
BH Brigham and Women's Hospital: 4 patents #209 of 1,764Top 15%
FI Fibralign: 2 patents #7 of 12Top 60%
GE: 1 patents #19,878 of 36,430Top 55%
BU Board Of Trustees Leland Stanford Jr University: 1 patents #50 of 153Top 35%
PR Panorama Research: 1 patents #7 of 20Top 35%
AC Ajinomoto Co.: 1 patents #1,164 of 2,190Top 55%
📍 Palo Alto, CA: #381 of 9,675 inventorsTop 4%
🗺 California: #8,171 of 386,348 inventorsTop 3%
Overall (All Time): #55,910 of 4,157,543Top 2%
49
Patents All Time

Issued Patents All Time

Showing 26–49 of 49 patents

Patent #TitleCo-InventorsDate
7452916 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity 2008-11-18
7390821 Methods of reducing angiogenesis Christopher Heeschen, Michael Weis 2008-06-24
7160904 Nicotine in therapeutic angiogenesis and vasculogenesis James Jang, Phillip Tsao, Christopher Heescheen 2007-01-09
7045534 Methods of reducing angiogenesis Christopher Heeschen, Michael Weis 2006-05-16
6896339 Methods and system for controlling latching exhaust valves Robert Moffitt, Kelly Gatson Swartz 2005-05-24
6720340 Nicotine receptor agonists in stem cell and progenitor cell recruitment Frances L. Johnson, Anjali Pathak, James Jang, Phillip Tsao, Christopher Heeschen 2004-04-13
6646006 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity Victor J. Dzau, Gary H. Gibbons 2003-11-11
6642208 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity Victor J. Dzau, Gary H. Gibbons 2003-11-04
6605115 Method and composition for inhibiting cardiovascular cell proliferation Garrison C. Fathman, Jonathan B. Rothbard, Shiro Uemura, Robert C. Robbins, Murray H. Kown 2003-08-12
6417205 Nicotine in therapeutic angiogenesis and vasculogenesis James Jang, Phillip Tsao, Christopher Heeschen 2002-07-09
6358699 Assay for asymmetrical NG, NG dimethyl-l-arginine Robert Balint, Mitchell Mutz 2002-03-19
6337321 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity Victor J. Dzau, Gary H. Gibbons 2002-01-08
6117872 Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity Andrew James Maxwell 2000-09-12
6063432 Arginine or lysine containing fruit healthbar formulation Andrew James Maxwell, Thomas Radke 2000-05-16
5945452 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity Victor J. Dzau, Gary H. Gibbons 1999-08-31
5891459 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity Victor J. Dzau, Gary H. Gibbons 1999-04-06
5861168 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury Sverin Schwarzacher, Tai T. Lim, Alan Yeung 1999-01-19
5852058 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury Sverin Schwarzacher, Tai T. Lim, Alan Yeung 1998-12-22
5536723 S-nitroso derivatives of hydrazinoacetic acids, 1-[(acylthio and (mercapto)-1-oxoalkyl]-1,2,34-Tetrahydroquinoline-2-carboxylic acids and alanyl prolines and isoquinolines Joseph Loscalzo 1996-07-16
5428070 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity Victor J. Dzau, Gary H. Gibbons 1995-06-27
5356890 S-nitroso derivatives of ace inhibitors and the use thereof Joseph Loscalzo 1994-10-18
5187183 S-nitroso derivatives of ACE inhibitors and the use thereof Joseph Loscalzo 1993-02-16
5025001 S-nitroso derivatives of ACE inhibitors and the use thereof Joseph Loscalzo 1991-06-18
4210252 Angleworm storage box Walter Rohrbach 1980-07-01